Immunocore Files Q1 2025 10-Q
Ticker: IMCR · Form: 10-Q · Filed: May 7, 2025 · CIK: 1671927
| Field | Detail |
|---|---|
| Company | Immunocore Holdings PLC (IMCR) |
| Form Type | 10-Q |
| Filed Date | May 7, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, biotech
TL;DR
Immunocore's Q1 2025 10-Q is in - check financials for latest updates.
AI Summary
Immunocore Holdings plc filed its 10-Q for the period ending March 31, 2025. The company reported revenue from the sale of therapies and collaboration revenue for the first quarter of 2025, though specific dollar amounts for these are not detailed in this header information. The filing also includes details on the company's financial structure as of December 31, 2024, such as common stock and retained earnings.
Why It Matters
This filing provides investors with an update on Immunocore's financial performance and position for the first quarter of 2025, crucial for assessing the company's ongoing operations and future prospects.
Risk Assessment
Risk Level: medium — As a biotechnology company, Immunocore's financial performance is subject to the inherent risks of drug development and market adoption.
Key Numbers
- Q1 2025 — Reporting Period (First quarter of 2025 financial performance)
- 2024-12-31 — Balance Sheet Date (Financial position as of year-end 2024)
Key Players & Entities
- Immunocore Holdings plc (company) — Filer
- 20250331 (date) — Reporting Period End Date
- 20250507 (date) — Filing Date
- 0001671927 (company) — Central Index Key
FAQ
What were the specific revenue figures for the sale of therapies in Q1 2025?
The provided header information does not contain specific dollar amounts for the sale of therapies in Q1 2025, only the reporting period.
What was the total collaboration revenue for the first quarter of 2025?
The header information indicates collaboration revenue was reported for Q1 2025, but the specific amount is not detailed.
What is Immunocore's fiscal year end?
Immunocore's fiscal year ends on December 31.
When was the company formerly known as Immunocore Ltd?
The company was formerly known as Immunocore Ltd until April 12, 2016.
What is the company's SIC code?
Immunocore Holdings plc's Standard Industrial Classification (SIC) code is 2836 for Biological Products (No Diagnostic Substances).
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 7, 2025 regarding Immunocore Holdings plc (IMCR).